Please login to the form below

Not currently logged in


This page shows the latest respiratory news and features for those working in and with pharma, biotech and healthcare.

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

Drug reduced lower respiratory tract infections caused by respiratory syncytial virus in infants. ... Nearly all children will contract the virus before age two, leading to nearly 30 million acute lower respiratory tract infections globally each year.

Latest news

More from news
Approximately 27 fully matching, plus 603 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 85 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 28 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....